• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action.

作者信息

Drucker Daniel J

机构信息

Department of Medicine, Banting and Best Diabetes Centre, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Ontario, Canada.

出版信息

Diabetes Care. 2007 Jun;30(6):1335-43. doi: 10.2337/dc07-0228. Epub 2007 Mar 2.

DOI:10.2337/dc07-0228
PMID:17337495
Abstract
摘要

相似文献

1
Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action.二肽基肽酶-4抑制与2型糖尿病的治疗：临床前生物学及作用机制
Diabetes Care. 2007 Jun;30(6):1335-43. doi: 10.2337/dc07-0228. Epub 2007 Mar 2.
2
Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications.二肽基肽酶-4抑制剂：临床数据及临床意义
Diabetes Care. 2007 Jun;30(6):1344-50. doi: 10.2337/dc07-0233. Epub 2007 Mar 2.
3
Dipeptidyl peptidase IV inhibitors and the incretin system in type 2 diabetes mellitus.二肽基肽酶IV抑制剂与2型糖尿病中的肠促胰岛素系统
Pharmacotherapy. 2007 Aug;27(8):1163-80. doi: 10.1592/phco.27.8.1163.
4
[Sitagliptin. Dipeptidylpeptidase 4 inhibitor for patients with diabetes mellitus type 2].[西他列汀。用于2型糖尿病患者的二肽基肽酶4抑制剂]
Med Monatsschr Pharm. 2007 Aug;30(8):282-6; quiz 287-8.
5
[Dipeptidylpeptidase IV inhibitors and dual action PPAR-agonists].[二肽基肽酶IV抑制剂和双重作用的过氧化物酶体增殖物激活受体激动剂]
Med Monatsschr Pharm. 2006 Mar;29(3):93-6.
6
Incretin mimetics vie for slice of type 2 diabetes market.肠促胰岛素类似物争夺2型糖尿病市场份额。
Nat Biotechnol. 2007 Mar;25(3):263. doi: 10.1038/nbt0307-263. Epub 2007 Mar 1.
7
Pharmacodynamics of vildagliptin in patients with type 2 diabetes during OGTT.维格列汀在2型糖尿病患者口服葡萄糖耐量试验期间的药效学
J Clin Pharmacol. 2007 May;47(5):633-41. doi: 10.1177/0091270006299137.
8
MK-431 (Merck).MK - 431（默克公司）
Curr Opin Investig Drugs. 2005 Apr;6(4):419-26.
9
New treatments for diabetes.糖尿病的新疗法。
N Engl J Med. 2007 May 24;356(21):2221; author reply 2222-3.
10
New treatments for diabetes.
N Engl J Med. 2007 May 24;356(21):2222; author reply 2222-3.

引用本文的文献

1
Molecular Insights into the Potential Cardiometabolic Effects of GLP-1 Receptor Analogs and DPP-4 Inhibitors.胰高血糖素样肽-1受体类似物和二肽基肽酶-4抑制剂潜在心脏代谢效应的分子见解
Int J Mol Sci. 2025 Jul 15;26(14):6777. doi: 10.3390/ijms26146777.
2
The role of myocardial fibrosis in the diabetic cardiomyopathy.心肌纤维化在糖尿病性心肌病中的作用。
Diabetol Metab Syndr. 2025 Jun 24;17(1):242. doi: 10.1186/s13098-025-01783-9.
3
Research Progress on the Influence of Novel Targeted Drugs for Osteoporosis on Glucose Metabolism.骨质疏松症新型靶向药物对糖代谢影响的研究进展
Biomolecules. 2025 Feb 25;15(3):331. doi: 10.3390/biom15030331.
4
Bile acids and incretins as modulators of obesity-associated atherosclerosis.胆汁酸和肠促胰岛素作为肥胖相关动脉粥样硬化的调节因子
Front Cardiovasc Med. 2025 Jan 6;11:1510148. doi: 10.3389/fcvm.2024.1510148. eCollection 2024.
5
Role and mechanism of specialized pro-resolving mediators in obesity-associated insulin resistance.肥胖相关胰岛素抵抗中特异性促解决介质的作用及机制。
Lipids Health Dis. 2024 Jul 30;23(1):234. doi: 10.1186/s12944-024-02207-9.
6
Functional roles of CD26/DPP4 in lipopolysaccharide-induced lung injury.CD26/DPP4 在脂多糖诱导的肺损伤中的功能作用。
Am J Physiol Lung Cell Mol Physiol. 2024 May 1;326(5):L562-L573. doi: 10.1152/ajplung.00392.2022. Epub 2024 Mar 12.
7
DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature.用于治疗2型糖尿病的二肽基肽酶-4抑制剂——炒作还是希望？基于当前文献的分析
Front Mol Biosci. 2023 May 23;10:1130625. doi: 10.3389/fmolb.2023.1130625. eCollection 2023.
8
Polymer-Based Nanostructures for Pancreatic Beta-Cell Imaging and Non-Invasive Treatment of Diabetes.用于胰腺β细胞成像及糖尿病无创治疗的聚合物基纳米结构
Pharmaceutics. 2023 Apr 11;15(4):1215. doi: 10.3390/pharmaceutics15041215.
9
Global Epidemiology, Health Outcomes, and Treatment Options for Patients With Type 2 Diabetes and Kidney Failure.2型糖尿病合并肾衰竭患者的全球流行病学、健康结局及治疗选择
Front Clin Diabetes Healthc. 2021 Aug 23;2:731574. doi: 10.3389/fcdhc.2021.731574. eCollection 2021.
10
In Vitro Assessment Methods for Antidiabetic Peptides from Legumes: A Review.豆类抗糖尿病肽的体外评估方法：综述
Foods. 2023 Feb 2;12(3):631. doi: 10.3390/foods12030631.